[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335884-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335884-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overcoming-cancer-risk-in-inflammatory-bowel-disease-new-insights-into-preventive-strategies-and-pathogenesis-mechanisms-including-interactions-of-immune-cells-cancer-signaling-pathways-and-gut-microbiota","Overcoming cancer risk in inflammatory bowel disease - new insights into preventive strategies and pathogenesis mechanisms - including interactions of immune cells, cancer signaling pathways, and gut microbiota","","Inflammatory bowel disease (IBD), dominated by Crohn’s disease and ulcerative colitis, drives cancer risk through chronic gastrointestinal inflammation. Progression from inflammation to carcinogenesis is explained by coordinated interactions among immune cells, epithelial cancer signaling pathways, and gut microbiota, with persistent inflammation promoting mutation accumulation and abnormal pathway activation. Immune dysregulation and intestinal dysbiosis are presented as central mechanisms in IBD and colitis-associated colorectal cancer. The review emphasizes proactive inflammation management plus regular endoscopic and tumor screening as the most direct preventive approach.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overcoming-cancer-risk-in-inflammatory-bowel-disease-new-insights-into-preventive-strategies-and-pathogenesis-mechanisms-including-interactions-of-immune-cells-cancer-signaling-pathways-and-gut-microbiota/335884/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overcoming-cancer-risk-in-inflammatory-bowel-disease-new-insights-into-preventive-strategies-and-pathogenesis-mechanisms-including-interactions-of-immune-cells-cancer-signaling-pathways-and-gut-microbiota/335884.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are the two main forms of inflammatory bowel disease discussed in the review?","Question",{"text":63,"@type":64},"The review identifies Crohn’s disease (CD) and ulcerative colitis (UC) as the two most common forms of IBD.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does chronic inflammation in IBD contribute to cancer development?",{"text":68,"@type":64},"Long-term hyperactive inflammation can accumulate epithelial mutations and activate carcinogenic signaling pathways, supporting progression from inflammation to dysplasia and tumor formation.",{"name":70,"@type":61,"acceptedAnswer":71},"Which strategy is presented as the most direct way to prevent IBD-associated cancer?",{"text":72,"@type":64},"Proactive management of inflammation combined with regular endoscopic and tumor screenings is described as the most direct and effective strategy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335884,1790110357,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","TYPE Review  \nPUBLISHED 15 January 2024  \nDOI 10.3389/fimmu.2023.1338918  \nOPEN ACCESS  \nEDITED BY Fei Mao,  \nJiangsu University, China  \nREVIEWED BY  \nShenghong Zhang,  \nThe First Afﬁliated Hospital of Sun Yat-sen University, China  \nZhi Chen,  \nUniversity of Oulu, Finland  \n*CORRESPONDENCE Mingsong Li  \n [lims661216@163.com](lims661216@163.com)[ ](lims661216@163.com)Yan Sun  \n [2010683015@gzhmu.edu.cn](2010683015@gzhmu.edu.cn)  \nRECEIVED 15 November 2023  \nACCEPTED 26 December 2023  \nPUBLISHED 15 January 2024  \nCITATION  \nZhang H, Shi Y, Lin C, He C, Wang S, Li Q, Sun Y and Li M (2024) Overcoming cancer risk in inﬂammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Front. Immunol. 14:1338918 .  \ndoi: 10.3389/fimmu.2023.1338918  \nCOPYRIGHT  \n© 2024 Zhang, Shi, Lin, He, Wang, Li, Sun and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nOvercoming cancer risk in inﬂammatory bowel disease:  \nnew insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota  \nHaonan Zhang 1, Yulu Shi 2, Chanchan Lin 3, Chengcheng He 1, Shanping Wang 1, Qingyuan Li 4, Yan Sun 1* and Mingsong Li 1*  \n1 Inﬂammatory Bowel Diseases Research Center, Department of Gastroenterology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, The Third Afﬁliated Hospital of Guangzhou Medical University, Guangzhou, China, 2 Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China, 3 Department of Gastroenterology, Quanzhou First Hospital Afﬁliated to Fujian Medical University, Quanzhou, Fujian, China, 4Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China  \nInﬂammatory bowel disease (IBD), characterized primarily by gastrointestinal inﬂammation, predominantly manifests as Crohn’s disease (CD) and ulcerative colitis (UC) . It is acknowledged that Inﬂammation plays a signiﬁcant role in cancer development and patients with IBD have an increased risk of various cancers. The progression from inﬂammation to carcinogenesis in IBD is a result of the interplay between immune cells, gut microbiota, and carcinogenic signaling pathways in epithelial cells. Long-term chronic inﬂammation can lead to the accumulation of mutations in epithelial cells and the abnormal activation of carcinogenic signaling pathways. Furthermore, Immune cells play a pivotal role in both the acute and chronic phases of IBD, contributing to the transformation from inﬂammation to tumorigenesis. And patients with IBD frequently exhibit dysbiosis of the intestinal microbiome . Disruption of the gut microbiota and subsequent immune dysregulation are central to the pathogenesis of both IBD and colitis associated colorectal cancer (CAC) . The proactive management of inﬂammation combined with regular endoscopic and tumor screenings represents the most direct and effective strategy to prevent the IBDassociated cancer.  \nKEYWORDS  \ninﬂammatory bowel disease, inﬂammation associated cancer, cancer risk, immune cells, cancer prevention  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nInﬂammatory bowel disease (IBD) is a chronic inﬂammatory disorder of unclear etiology and unknown mechanisms, primarily involving inﬂammation of the gas","cbCaioUxjz3FDfnh","https://ap.wps.com/l/cbCaioUxjz3FDfnh","pdf",2459989,17,"English","# 1 Introduction\n# 2 The risk of cancer associated with IBD\n## 2.1 Colorectal and anal cancer","[{\"question\":\"What are the two main forms of inflammatory bowel disease discussed in the review?\",\"answer\":\"The review identifies Crohn’s disease (CD) and ulcerative colitis (UC) as the two most common forms of IBD.\"},{\"question\":\"How does chronic inflammation in IBD contribute to cancer development?\",\"answer\":\"Long-term hyperactive inflammation can accumulate epithelial mutations and activate carcinogenic signaling pathways, supporting progression from inflammation to dysplasia and tumor formation.\"},{\"question\":\"Which strategy is presented as the most direct way to prevent IBD-associated cancer?\",\"answer\":\"Proactive management of inflammation combined with regular endoscopic and tumor screenings is described as the most direct and effective strategy.\"}]","Overcoming cancer risk in inflammatory bowel disease - new insights into preventive strategies and pathogenesis mechanisms - including interactions of immune cells, cancer signaling pathways, and gut microbiota | PDF",1790012710,43]